首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2020年 6期“非酒精性脂肪性肝病与多代谢紊乱的基础与临床” => 述评 =>非酒精性脂肪性肝病更..
非酒精性脂肪性肝病更名带来的新思考
New thoughts about renaming nonalcoholic fatty liver disease
文章发布日期:2020年06月01日  来源:  作者:高鑫  点击次数:392次  下载次数:212次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:非酒精性脂肪性肝病(NAFLD)是一种代谢紊乱相关的多系统疾病,在肥胖和2型糖尿病(T2DM)患者中更为常见,而且与这两个共患疾病有着相似的不良结局。长期以来,NAFLD的重点强调肝脏病变和肝病相关结局,内分泌科医生按照目前糖尿病临床指南处理T2DM的同时往往忽视了对肝脏病变的筛查、诊断与处理。因此,在实际工作中,将NAFLD更名为代谢相关脂肪性肝病有着重要的现实意义。以降低肝脂肪含量为目标的防治T2DM的策略需要多学科临床与基础合作,以共同理念防治肥胖、脂肪肝、糖尿病,才能将最常见的慢性病防治落到实处。
【Abstract】:Nonalcoholic fatty liver disease (NAFLD) is a multisystem disease involving metabolic disorder and is more common in patients with obesity and type 2 diabetes mellitus (T2DM), with similar adverse outcomes to these two comorbidities. For a long time, NAFLD has emphasized liver lesions and outcomes of liver diseases, and when treating T2DM according to the current clinical guidelines for diabetes, endocrinologists often neglect the screening, diagnosis, and treatment of liver lesions. Therefore, in clinical practice, NAFLD renamed as metabolic-associated fatty liver disease has important practical significance. Strategies for T2DM prevention and treatment aiming at reducing liver lipid content require multidisciplinary cooperation, and prevention and treatment of obesity, fatty liver disease, and diabetes with the same concepts can help to implement the prevention and treatment of the most common chronic diseases.
【关键字】:非酒精性脂肪性肝病; 代谢相关脂肪性肝病; 科学术语(主题)
【Key words】:non-alcoholic fatty liver disease; metabolic associated fatty liver disease; terminology as topic
【引证本文】:GAO X. New thoughts about renaming nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2020, 36(6): 1201-1204. (in Chinese)
高鑫. 非酒精性脂肪性肝病更名带来的新思考[J]. 临床肝胆病杂志, 2020, 36(6): 1201-1204.

相关文章
地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号